Béliard, Sophie http://orcid.org/0000-0002-6000-5028
Mourre, Florian http://orcid.org/0000-0003-3695-4095
Valéro, René http://orcid.org/0000-0002-2176-3280
Article History
Received: 5 October 2023
Accepted: 7 December 2023
First Online: 20 February 2024
Funding
: The authors received no funding linked to this article.
: SB received honoraria from Amarin, Amgen, Amryt, Novartis, Sanofi and Ultragenyx for lectures and for boards (Novartis, Ultragenyx) and participated in trials for Akcea, Ionis, Amgen, Novartis and Sanofi-Regeneron. RV received honoraria from Amarin, Amgen, Arrowhead, Servier and Sanofi for lectures and participated in trials for Akcea, Ionis, Amgen, Novartis and Sanofi-Regeneron. FM participated in trials for Akcea, Ionis, Amgen, Novartis and Sanofi-Regeneron.
: All authors were responsible for drafting the article and reviewing it critically for important intellectual content. All authors approved the version to be published.